METASTATIS: BIOLOGICAL PHENOTYPE AND MODELS FOR THERAPY
METASTATIS: BIOLOGICAL PHENOTYPE AND MODELS FOR THERAPY
批准号:
3190674
负责人:
DOROTHEE M HERLYN
金额:
$19.09万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1989
资助国家:
美国
项目状态:
已结题
起止时间:
1989-06-21 至 1992-05-31
关键词:
athymic mouse basement membrane carcinoma cellular oncology clone cells deficient growth media enzyme mechanism extracellular matrix fibroblast growth factor growth factor high performance liquid chromatography host neoplasm interaction human tissue melanoma membrane model metastasis monoclonal antibody neoplasm /cancer classification /staging neoplasm /cancer immunotherapy neoplasm /cancer invasiveness neoplasm /cancer transplantation neoplastic cell peptidases platelet derived growth factor protease inhibitor rectum neoplasms transforming growth factors tumor antigens
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Cells isolated from early and advanced stages of tumor progression of two
human malignancies of different embryological origin, colorectal carcinoma
and melanoma, have been maintained in tissue culture for immunological,
biological, and molecular investigations. The proposed studies are intended
to experimentally dissect the sequential steps of the metastatic cascade,
i.e., attachment to and invasion of basement membranes, and survival and
growth during and after dissemination. Our working hypothesis is that
malignant cells from primary lesions require at least two properties for
progression to the metastatic phenotype: invasiveness, i,e. the ability to
survive and proliferate at clonal densities under nutrient-depleted growth
conditions. Our experimental models will be cell variants selected from
primary, non-invasive lesions that are invasive in vitro in reconstructed
basement membrane models and in vivo in athymic nude mice. We also have
cell lines available that were established from primary and metastatic
lesions of the same patients. These spontaneously and experimentally
derived models will provide the basis for a comparative analysis of the
activity of proteolytic enzymes such as metalloproteinases and serine
proteinases and of their interactions with specific inhibitors. Endogenous
growth factors, including fibroblast growth factors and transforming growth
factors, may not only be responsible for growth autonomy of metastatic
cells but might also exert a regulatory role in invasion by activating
either proteolytic enzymes or enzyme inhibitors.
Blocking the attachment of tumor cells to substrate with monoclonal
antibodies (MAbs) can effectively disrupt the metastatic cascade. The
mechanisms by which MAbs to gangliosides GD2 and GD3 block attachment and
invasion of metastatic cells in tissue culture and also inhibit metastatic
tumor cell spread in the nude mouse model will be explored. A new class of
basement membrane-related antigens as defined with MAbs mi utilize
gangliosides as receptors for attachment and thereby may constitute
attachment factors for metastasizing cells. The biochemical, and functional
analysis of antigens involved in attachment and invasion will help to
identify common biological and immunological properties of invasive and
metastatic tumor cells in vitro and in vivo as a preclinical study for the
development of therapeutic approaches in cancer patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Breaking tolerance to mEGP self-antigen
-
批准号:7164454
-
项目类别:
-
资助金额:$22.25万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7536069
-
项目类别:
-
资助金额:$23.92万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7030572
-
项目类别:
-
资助金额:$22.62万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Breaking tolerance to mEGP self-antigen
-
批准号:7323314
-
项目类别:
-
资助金额:$19.75万
-
财政年份:2006
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CTL-based Immunotherapy in an Organotypic Me
-
批准号:6990749
-
项目类别:
-
资助金额:$15.91万
-
财政年份:2004
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6611550
-
项目类别:
-
资助金额:$25.3万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6735640
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
EGF-RvIII in Breast Cancer
-
批准号:6868153
-
项目类别:
-
资助金额:$25.91万
-
财政年份:2003
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6563877
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6563878
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6594573
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6659180
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2002
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6410218
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6459000
-
项目类别:
-
资助金额:$31.28万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6410217
-
项目类别:
-
资助金额:$22.84万
-
财政年份:2001
-
负责人:DOROTHEE M HERLYN
-
依托单位:
PATIENTS' IMMUNE RESPONSES
-
批准号:6300548
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
CORE--IMMUNOLOGY
-
批准号:6300549
-
项目类别:
-
资助金额:$15.41万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS
-
批准号:6443294
-
项目类别:
-
资助金额:$35.44万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
MOLECULAR CLONING OF HLA CLASS II TUMOR ANTIGENS
-
批准号:6633842
-
项目类别:
-
资助金额:$31.8万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
Melanoma antigens recognized by B and T helper lymphocytes
-
批准号:6300192
-
项目类别:
-
资助金额:$13.09万
-
财政年份:2000
-
负责人:DOROTHEE M HERLYN
-
依托单位:
海外基金